CCHFVaccine is a six year project started in January 2017, coordinated by Folkhälsomyndigheten (the Public Institute of Sweden, FoHM, Professor Ali Mirazimi) in Sweden.

Our collaborative network brings together 14 complementary partners, including 13 research institution and one technology transfer / management company.

The project is supported by the European Commission under the H2020 Programme.

The CCHFVaccine project, has been built on the success of the CCH Fever project (FP7), which had focused on improving the knowledge of CCHFV, in general.

The specific aim of the CCHFVaccine project is to develop and deliver a vaccine, which can significantly increase our capacity to control the situation of Crimean Congo Haemorrhagic fever (CCHF) disease on a global basis.